← All organizations

Institut Jerome Lejeune

Academic/HospitalWebsite ↗

Also known as: Institut Jerome Lejeune | Institut Jerome Lejeune, Paris, France

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 29, 2018

Timeline

1990s

Jan 1, 1997
Institut Jerome Lejeune— Founded

Drugs by trial phase (3 distinct, 3 trials)

Phase 3 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

l-epigallocatechin

Indications

Studied for

Recent trials (6)

NCT03624556CollaboratorN/AJan 29, 2018
NCT01576705Lead sponsorPhase 3Apr 1, 2012
NCT01576705Overall official - principal investigatorPhase 3Apr 1, 2012
NCT00294593Overall official - principal investigatorPhase 2/Phase 3Oct 1, 2000
NCT00294593Study directorPhase 2/Phase 3Oct 1, 2000
NCT00294593Lead sponsorPhase 2/Phase 3Oct 1, 2000

Details

Founded: Paris, FR Jan 1, 1997
Last known activity: Jan 29, 2018